The GvHD is a major cause of morbidity and mortality after allogeneic hematopoietic stem
cell transplantation (HSCT). Extracorporeal photopheresis (ECP) represents an alternative …

Current understanding of the immunomodulatory mechanisms of extracorporeal
photopheresis (ECP) is that 8-methoxypsoralen incubation and UVA exposure of peripheral …

Abstract The First International Symposium on Photopheresis in Hematopoietic Stem Cell
Transplantation was held in Vienna, Austria with an educational grant from Therakos Inc …

Despite significant advances in stem cell manipulation and post-transplant
immunosuppression, chronic graft-versus-host disease (cGVHD) remains a cause of major …

Extracorporeal photopheresis (ECP) constitutes a promising treatment for patients with
steroid-refractory acute graft-versus-host disease (aGvHD) after allogeneic stem cell …

Acute graft-versus-host disease (aGVHD) is a major complication of allogeneic
hematopoietic cell transplantation (HCT). In 1966, Billingham defined three criteria for the …

Chronic GVHD (cGVHD) is a major limitation of allogeneic hematopoietic cell
transplantation. Extracorporeal photopheresis therapy (ECP) has been used in retrospective …

BACKGROUND:: Extracorporeal photopheresis (ECP) is an effective treatment for some
malignant T cell proliferations and disorders associated with pathogenic T cell activation …

Graft-versus-host disease (GVHD) is a major cause of mortality and morbidity following
allogeneic hematopoietic stem cell transplantation. Extracorporeal photopheresis (ECP) …

Graft-versus-host disease (GVHD) is a major complication of allogeneic bone marrow
transplantation. Extracorporeal photochemotherapy (ECP) has been introduced as an …